Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery

Pharmacotherapy

Volumn 26, Issue 4, 2006, Pages 499-504

  Gillespie, Effie L ^a,b   White, C Michael ^a,b   Kluger, Jeffrey ^b,c   Rancourt, James A ^b   Gallagher, Robert ^b   Coleman, Craig I ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Amiodarone; Atrial fibrillation; Cardiothoracic surgery; Cost effectiveness; Costs

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN;

ADULT; AGED; ARTICLE; CALCULATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONEY; NONPARAMETRIC TEST; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; RETROSPECTIVE STUDY; THORAX SURGERY; UNITED STATES;

EID: 33645688888     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.4.499     Document Type: Article

References (34)

1. American Heart Association. 2002 Heart and stroke statistical update. Available from www.americanheart.org/downloadable/heart/ 10148328094661013190990123HS_State_02.pdf. Accessed August 7, 2002.
2. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001;135:1061-73.
3. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539-49.
4. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary bypass graft surgery. JAMA 1996;276:300-6.
5. Auer J, Weber T, Berent R, et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 2004;147:636-43.
6. Butler J, Harriss DR, Sinclair M, Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. Br Heart J 1993;70:56-60.
7. Daoud EG, Strickberger SA, Man C, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997;337:1785-91.
8. Dorge H, Schoendube FA, Schoberer M, Stellbrink C, Voss M, Messmer BJ. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Sur 2000;69:1358-62.
9. Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the atrial fibrillation suppression trial (AFIST): a randomised placebo-controlled trial. Lancet 2001;357:830-6.
10. Guarnieri T, Nolan S, Gottlieb SO, Dudek A, Lowry D. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial. J Am Coll Cardiol 1999;34:343-7.
11. Hohnloser SH, Meinertz T, Dammbacher T, et al. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991;121:89-95.
12. Lee SH, Chang CM, Lu MJ, et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2000;70:157-61.
13. Maras D, Boskovic SD, Popovic Z, et al. Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. Am Heart J 2001;141:E8.
14. Mitchell LB, Exner DV, Wyse DG, et al. Prophylactic amiodarone for the prevention of arrhythmias that begin early after revascularization, valvular repair, or replacement (PAPABEAR): preliminary results [abstr]. Circulation 2004;108:2723.
15. Redle JD, Khurana S, Marzan R, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 1999;138:144-50.
16. White CM, Caron MF, Kalus JS, et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the atrial fibrillation suppression trial 11 (AFIST 11). Circulation 2003;108(suppl 11):11-200-6.
17. Treggiari-Venzi MM, Waeber JL, Perneger TV, Suter, PM, Adamec R, Romand JA. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. Br J Anaesth 2000;85:690-5.
18. Yagdi T, Nalbantgil S, Ayik F, et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1420-5.
19. Yazigi A, Rahbani P, Zeid HA, Madi-Jebara S, Haddad F, Hayek G. Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. J Cardiothorac Vasc Anesth 2002;16:603-6.
20. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002;106:75-80.
21. Zimmer J, Pezzullo J, Choucair W, et al. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, cost, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 2003;91:1137-40.
22. Gillespie EL, Coleman CI, Sander S, Kluger J, Gryskiewicz KA, White CM. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother 2005;39:1409-15.
23. Perkerson KA, Gillespie EL, White CM, et al. Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 2005;25:320-4.
24. Kalus JS, White CM, Caron MF, et al. Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg 2004;77:1288-92.
25. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med 1998;17:2265-81.
26. Society of Thoracic Surgeons. STS national database. STS adult cardiac database: definitions of terms. Available from www.sts.org/doc/8428. Accessed June 1, 2005.
27. Eisenberg JM. Clinical economics. A guide to the economic analysis of clinical practices. JAMA 1989;262:2879-86.
28. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
29. U.S. Bureau of Labor Statistics. Consumer price indexes detailed report. Washington, DC: Department of Labor, March 2004. Available from http://www.bls.gov/cpi/. Accessed June 26, 2005.
30. Hunink MGH, Bult JR, De Vries J, et al. Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method. Med Decis Making 1998;18:337-46.
31. Reddy P, Dunn AB, White CM, Tsikouris JP, Giri S, Kluger J. An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery. Pharmacotherapy 2002;22:75-80.
32. Reddy P, Kalus JS, Caron MF, et al. Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. Pharmacotherapy 2004;24:1013-19.
33. Connolly SJ, Cybulsky I, Lamy A, et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-blocker length of stay (BLOS) study. Am Heart J 2003;145:226-32.
34. Fuster V, Ryden LE. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines and policy conferences. J Am Coll Cardiol 2001;38:1231-65.